{
    "Trade/Device Name(s)": [
        "Magnesium"
    ],
    "Submitter Information": "Abbott Laboratories",
    "510(k) Number": "K173294",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class I, reserved",
    "Product Code(s)": [
        "JGJ"
    ],
    "Summary Letter Date": "April 5, 2018",
    "Summary Letter Received Date": "April 10, 2018",
    "Submission Date": "May 11, 2018",
    "Regulation Number(s)": [
        "21 CFR 862.1495"
    ],
    "Regulation Name(s)": [
        "Magnesium test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Magnesium"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Serum glass tube",
        "Serum with gel separator",
        "Sodium heparin plasma (without gel separator)",
        "Lithium heparin plasma (without gel separator)",
        "Lithium heparin plasma with gel separator"
    ],
    "Instrument(s)/Platform(s)": [
        "ARCHITECT c8000 System"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic assay",
        "Rate-up enzymatic measurement"
    ],
    "Methodologies": [
        "Enzymatic"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Abbott Laboratories Magnesium assay, an enzymatic method for magnesium quantification in human serum or plasma using the ARCHITECT c8000 System",
    "Indications for Use Summary": "Used for quantitation of magnesium in human serum or plasma to aid in the diagnosis and treatment of hypomagnesemia and hypermagnesemia on the ARCHITECT c8000 System",
    "fda_folder": "Clinical Chemistry"
}